Target intelligence / Profile preview

RNA, U6 small nuclear 875, pseudogene (RNU6-875P)

Target: RNU6-875P
Molecular classification: Other (Non-coding RNA pseudogene)

Overview

RNA, U6 small nuclear 875, pseudogene (RNU6-875P) is a human genomic pseudogene derived from the U6 small nuclear RNA family. U6 snRNA itself is an essential part of the spliceosome, catalyzing intron excision from pre-mRNA in eukaryotic nuclei[3][5]. Pseudogenes such as RNU6-875P, common in the human genome, represent defective copies that are transcriptionally inactive and lack the biological functions of their parent genes[1]. Although some pseudogenes may act as regulatory RNA molecules in certain contexts, there is no evidence that RNU6-875P has such a role. This target is not a pharmacologically actionable molecule, and listing RNU6-875P as a receptor or therapeutic target would be a misclassification.

Other names: RNU6-875PRNA, U6 small nuclear 875, pseudogene

Mechanism of action

None applicable; RNU6-875P is not targeted by drugs.

Biological functions

No known biological functions as a pseudogene; it does not produce functional RNA or protein. By analogy to other pseudogenes, some may act as microRNA sponges, but this has not been established for RNU6-875P.

Disease associations

None established specifically for RNU6-875P. While some pseudogenes influence cancer or other diseases by acting as competitive endogenous RNAs, no disease associations are documented for RNU6-875P.

Safety considerations

None; as a non-coding pseudogene, RNU6-875P does not present therapeutic safety concerns.

Interacting drugs

None. No drugs are known to interact with RNU6-875P, as it is not an active target.

Biomarkers

None documented for RNU6-875P.

Beyond the preview

Go deeper on RNA, U6 small nuclear 875, pseudogene (RNU6-875P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 875, pseudogene (RNU6-875P).

Explore the full profile